Your browser doesn't support javascript.
loading
CRISIS AFAR: An International Collaborative Study of the Impact of the COVID-19 Pandemic on Youth with Autism and Neurodevelopmental Conditions.
Bethany Vibert; Patricia Segura; Louise Gallagher; Stelios Georgiades; Panagiota Pervanidou; Audrey Thurm; Lindsay Alexander; Evdokia Anagnostou; Yuta Aoki; Catherine S.N. Birken; Somer L. Bishop; Jessica Boi; Carmela Bravaccio; Helena Brentani; Paola Canevini; Alessandra Carta; Alice Charach; Antonella Costantino; Katherine T. Cost; Elaine Andrade Cravo; Jennifer Crosbie; Chiara Davico; Alessandra Gabellone; Federica Donno; Junya Fujino; Cristiane Tezzari Geyer; Tomoya Hirota; Stephen Kanne; Makiko Kawashima; Elizabeth Kelley; Hosanna Kim; Young Shin Kim; So Hyun (Sophy) Kim; Daphne J. Korczak; Meng-Chuan Lai; Lucia Margari; Gabriele Masi; Lucia Marzulli; Luigi Mazzone; Jane McGrath; Suneeta Monga; Paola Morosini; Shinichiro Nakajima; Antonio Narzisi; Rob Nicolson; Aki Nikolaidis; Yoshihiro Noda; Kerri Nowell; Miriam Polizzi; Joana Portolese; Maria Pia Riccio; Manabu Saito; Anish K. Simhal; Martina Siracusano; Stefano Sotgiu; Jacob Stroud; Fernando Sumiya; Ida Schwartz; Yoshiyuki Tachibana; Nicole Takahashi; Riina Takahashi; Hiroki Tamon; Raffaella Tancredi; Benedetto Vitiello; Alessandro Zuddas; Bennett Leventhal; Kathleen Merikangas; Michael P. Milham; Adriana Di Martino.
Afiliação
  • Bethany Vibert; Autism Center, Child Mind Institute, New York, NY, USA
  • Patricia Segura; Autism Center, Child Mind Institute, New York, NY, USA
  • Louise Gallagher; Department of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland
  • Stelios Georgiades; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada
  • Panagiota Pervanidou; University of Athens, National & Kapodistrian University of Athens, School of Medicine, First Department of Pediatrics, Unit of Developmental and Behavioral Ped
  • Audrey Thurm; Neurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health, Bethesda, Maryland, USA
  • Lindsay Alexander; Center for the Developing Brain, Child Mind Institute, New York, NY, USA
  • Evdokia Anagnostou; Autism Research Centre, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, ON, Canada; Department of Paediatrics, University
  • Yuta Aoki; Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan
  • Catherine S.N. Birken; Department of Pediatrics, School of Medicine, University of Toronto, Toronto, ON, Canada; Division of Paediatric Medicine, Hospital for Sick Children, Toronto,
  • Somer L. Bishop; Department of Psychiatry and Behavioral Sciences and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA
  • Jessica Boi; Department of Biomedical Sciences, Section of Neuroscience & Clinical Pharmacology, University of Cagliari, Cagliari, Italy
  • Carmela Bravaccio; UOSD di Neuropsichiatria Infantile - Dipartimento di Scienze Mediche Traslazionali, Universita Federico II di Napoli - Italy
  • Helena Brentani; Department of Psychiatry, Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of Sao Paulo (USP), Sao Paulo, Brazil
  • Paola Canevini; Department of Health Sciences, Universita degli Studi di Milano,Milan, Italy; Epilepsy Center - Sleep Medicine Center, Childhood and Adolescence Neuropsychiatry
  • Alessandra Carta; Department of Medical Surgical and Experimental Sciences, Unit of Child Neuropsychiatry, University Hospital of Sassari, Sassari, Italy
  • Alice Charach; Department of Psychiatry, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, 6th Floor, Toronto, On, M5G 0A4, Canada; De
  • Antonella Costantino; Child and Adolescent Neuropsychiatric Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Katherine T. Cost; Department of Psychiatry, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, 6th Floor, Toronto, On, M5G 0A4, Canada
  • Elaine Andrade Cravo; Department of Psychiatry, School of Medicine, Universidade Federal do Parana, Curitiba, PR, Brazil
  • Jennifer Crosbie; Department of Psychiatry, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, 6th Floor, Toronto, On, M5G 0A4, Canada; De
  • Chiara Davico; Department of Public Health and Pediatric Sciences, Section of Child and Adolescent Neuropsychiatry, University of Turin, Turin, Italy
  • Alessandra Gabellone; Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy
  • Federica Donno; Department of Biomedical Sciences, Section of Neuroscience & Clinical Pharmacology, University of Cagliari, Cagliari, Italy
  • Junya Fujino; Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
  • Cristiane Tezzari Geyer; Department of Psychiatry, School of Medicine, Universidade Federal do Parana, Curitiba, PR, Brazil
  • Tomoya Hirota; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA; Department of Neuropsychiatry, Graduat
  • Stephen Kanne; Center for Autism and the Developing Brain, Department of Psychiatry, Weill Cornell Medicine, New York, NY
  • Makiko Kawashima; Koishikawa Tokyo Hospital, Tokyo, Japan
  • Elizabeth Kelley; Department of Psychology, Queens University, Kingston, ON, Canada
  • Hosanna Kim; The UCSF Center for ASD & NDDs, University of California San Francisco, San Francisco, California
  • Young Shin Kim; The UCSF Center for ASD & NDDs, University of California San Francisco, San Francisco, California
  • So Hyun (Sophy) Kim; Center for Autism and the Developing Brain, Department of Psychiatry, Weill Cornell Medicine, New York, NY
  • Daphne J. Korczak; Department of Psychiatry, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, 6th Floor, Toronto, On, M5G 0A4, Canada; De
  • Meng-Chuan Lai; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Autism Research Centre, Department of Psychiatry, University of C
  • Lucia Margari; Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy
  • Gabriele Masi; IRCCS Stella Maris Foundation, Pisa (Calambrone), Italy
  • Lucia Marzulli; Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy
  • Luigi Mazzone; Child Neurology and Psychiatry Unit, Systems Medicine Department,University of Rome Tor Vergata, Rome, Italy
  • Jane McGrath; Department of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland; ADMiRE, Linn Dara Child and Adolescent Mental Health Services, Cherry Orc
  • Suneeta Monga; Department of Psychiatry, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, 6th Floor, Toronto, On, M5G 0A4, Canada; De
  • Paola Morosini; Unita' Operativa di Neuropsichiatria dell' Infanzia e dell' adolescenza, Lodi, Italy
  • Shinichiro Nakajima; Keio University School of Medicine, Tokyo, Japan
  • Antonio Narzisi; IRCCS Stella Maris Foundation, Pisa (Calambrone), Italy
  • Rob Nicolson; Department of Psychiatry, University of Western Ontario, London, Ontario
  • Aki Nikolaidis; Center for the Developing Brain, Child Mind Institute, New York, NY, USA
  • Yoshihiro Noda; Keio University School of Medicine, Tokyo, Japan
  • Kerri Nowell; Thompson Center of Neurodevelopmental Disorders, University of Missouri, Columbia, MO, USA
  • Miriam Polizzi; UOSD di Neuropsichiatria Infantile - Dipartimento di Scienze Mediche Traslazionali, Universita Federico II di Napoli - Italy
  • Joana Portolese; Department of Psychiatry, Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of Sao Paulo (USP), Sao Paulo, Brazil
  • Maria Pia Riccio; UOSD di Neuropsichiatria Infantile - Dipartimento di Scienze Mediche Traslazionali, Universita Federico II di Napoli - Italy
  • Manabu Saito; Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Aomori, Japan; Research Center for Child Mental Development, Graduate
  • Anish K. Simhal; Autism Center, Child Mind Institute, New York, NY, USA; Medical Physics, Memorial Sloan Kettering Cancer Center, NY, USA
  • Martina Siracusano; Child Neurology and Psychiatry Unit, Systems Medicine Department,University of Rome Tor Vergata, Rome, Italy
  • Stefano Sotgiu; Department of Medical Surgical and Experimental Sciences, Unit of Child Neuropsychiatry, University Hospital of Sassari, Sassari, Italy
  • Jacob Stroud; Autism Center, Child Mind Institute, New York, NY, USA
  • Fernando Sumiya; Department of Psychiatry, Hospital das Clinicas HCFMUSP, Faculty of Medicine, University of Sao Paulo (USP), Sao Paulo, Brazil
  • Ida Schwartz; Medical Genetics Service/HCPA, Genetics Department/UFRGS, Brazil
  • Yoshiyuki Tachibana; Division of Infant and Toddler Mental Health, Department of Psychosocial Medicine, National Center for Child Health and Development, Tokyo, Japan
  • Nicole Takahashi; Thompson Center of Neurodevelopmental Disorders, University of Missouri, Columbia, MO, USA
  • Riina Takahashi; Koishikawa Tokyo Hospital, Tokyo, Japan
  • Hiroki Tamon; Division of Infant and Toddler Mental Health, Department of Psychosocial Medicine, National Center for Child Health and Development, Tokyo, Japan
  • Raffaella Tancredi; IRCCS Stella Maris Foundation, Pisa (Calambrone), Italy
  • Benedetto Vitiello; Department of Public Health and Pediatric Sciences, Section of Child and Adolescent Neuropsychiatry, University of Turin, Turin, Italy
  • Alessandro Zuddas; Department of Biomedical Sciences, Section of Neuroscience & Clinical Pharmacology, University of Cagliari, Cagliari, Italy; Child & Adolescent Neuropsychiatry
  • Bennett Leventhal; University of Chicago, Chicago, IL, USA
  • Kathleen Merikangas; Genetic Epidemiology Research Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA
  • Michael P. Milham; Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA
  • Adriana Di Martino; Autism Center, Child Mind Institute, New York, NY, USA
Preprint em Inglês | medRxiv | ID: ppmedrxiv-22274269
ABSTRACT
ImportanceHeterogeneous mental health outcomes during the COVID-19 pandemic are recognized in the general population, but it has not been systematically assessed in youth with neurodevelopmental disorders (NDD), including autism spectrum (ASD). ObjectiveIdentify subgroups of youth with ASD/NDD based on the pandemic impact on symptoms and service changes, as well as predictors of outcomes. Design, Setting, and ParticipantsThis is a naturalistic observational study conducted across 14 North American and European clinical and/or research sites. Parent responses on the Coronavirus Health and Impact Survey Initiative (CRISIS) adapted for Autism and Related Neurodevelopmental Conditions (AFAR) were cross-sectionally collected from April to October 2020. The sample included 1275, 5-21 year-old youth with ASD and/or NDD who were clinically well-characterized prior to the pandemic. Main Outcomes and MeasuresTo identify impact subgroups, hierarchical clustering analyzed eleven AFAR factors measuring pre- to pandemic changes in clinically relevant symptoms and service access. Random forest classification assessed the relative contribution in predicting subgroup membership of 20 features including socio-demographics, pre-pandemic service, and clinical severity along with indices of COVID-19 related experiences and environments empirically-derived from AFAR parent responses and global open sources. ResultsClustering analyses revealed four ASD/NDD impact subgroups. One subgroup - broad symptom worsening only (20% of the aggregate sample) - included youth with worsening symptoms that were above and beyond that of their ASD/NDD peers and with similar service disruptions as those in the aggregate average. The three other subgroups showed symptom changes similar to the aggregate average but differed in service access primarily modified services (23%), primarily lost services (6%), and average services/symptom changes (53%). Pre-pandemic factors (e.g., number of services), pandemic environments and experiences (e.g., COVID-19 cases, related restrictions, COVID-19 Worries), and age emerged in unique combinations as distinct protective or risk factors for each subgroup. Together they highlighted the role of universal risk factors, such as risk perception, and the protective role of services before and during the pandemic, in middle childhood. Conclusions and RelevanceConcomitant assessment of changes in both symptoms and services access is critical to understand heterogeneous impact of the pandemic on ASD/NDD youth. It enabled the delineation of pathways to risk and resilience that include universal and ASD/NDD specific contributors.
Licença
cc_by
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Estudo prognóstico / Pesquisa qualitativa / Rct Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Estudo prognóstico / Pesquisa qualitativa / Rct Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
...